Recently Released Market Study: Contact Lenses in the US
In May 2013, Bausch & Lomb was bought out by Valeant Pharmaceuticals, Canada's largest drug maker. Valeant will acquire the number four player within the US contact lenses market with nearly 10% market value share. The acquisition comes at a time when Bausch & Lomb is struggling to stay afloat and maintain its market share. Valeant hopes to profit from the growing contact lens solution market, which is being bolstered by an ageing population and growing numbers of contact lens...
View full press release